ASGE guideline: The management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures

Marc J. Zuckerman, William K. Hirota, Douglas G. Adler, Raquel E. Davila, Brian C. Jacobson, Jonathan A Leighton, Waqar A. Qureshi, Elizabeth Rajan, R. David Hambrick, Robert D. Fanelli, Todd H. Baron, Douglas Orrick Faigel

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

This is one of a series of statements discussing the utilization of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy prepared this text. In preparing this guideline, a MEDLINE literature search was performed, and additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When little or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus. Further controlled clinical studies are needed to clarify aspects of this statement, and revision may be necessary as new data appear. Clinical consideration may justify a course of action at variance to these recommendations.

Original languageEnglish (US)
Pages (from-to)189-194
Number of pages6
JournalGastrointestinal Endoscopy
Volume61
Issue number2
DOIs
StatePublished - Feb 2005

Fingerprint

Low Molecular Weight Heparin
Platelet Aggregation Inhibitors
Endoscopy
Guidelines
Gastrointestinal Endoscopy
Bibliography
Consultants
MEDLINE
Clinical Studies

ASJC Scopus subject areas

  • Gastroenterology

Cite this

ASGE guideline : The management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. / Zuckerman, Marc J.; Hirota, William K.; Adler, Douglas G.; Davila, Raquel E.; Jacobson, Brian C.; Leighton, Jonathan A; Qureshi, Waqar A.; Rajan, Elizabeth; Hambrick, R. David; Fanelli, Robert D.; Baron, Todd H.; Faigel, Douglas Orrick.

In: Gastrointestinal Endoscopy, Vol. 61, No. 2, 02.2005, p. 189-194.

Research output: Contribution to journalArticle

Zuckerman, MJ, Hirota, WK, Adler, DG, Davila, RE, Jacobson, BC, Leighton, JA, Qureshi, WA, Rajan, E, Hambrick, RD, Fanelli, RD, Baron, TH & Faigel, DO 2005, 'ASGE guideline: The management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures', Gastrointestinal Endoscopy, vol. 61, no. 2, pp. 189-194. https://doi.org/10.1016/S0016-5107(04)02392-2
Zuckerman, Marc J. ; Hirota, William K. ; Adler, Douglas G. ; Davila, Raquel E. ; Jacobson, Brian C. ; Leighton, Jonathan A ; Qureshi, Waqar A. ; Rajan, Elizabeth ; Hambrick, R. David ; Fanelli, Robert D. ; Baron, Todd H. ; Faigel, Douglas Orrick. / ASGE guideline : The management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. In: Gastrointestinal Endoscopy. 2005 ; Vol. 61, No. 2. pp. 189-194.
@article{e98781839f2a468dab8286f95e2005d8,
title = "ASGE guideline: The management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures",
abstract = "This is one of a series of statements discussing the utilization of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy prepared this text. In preparing this guideline, a MEDLINE literature search was performed, and additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When little or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus. Further controlled clinical studies are needed to clarify aspects of this statement, and revision may be necessary as new data appear. Clinical consideration may justify a course of action at variance to these recommendations.",
author = "Zuckerman, {Marc J.} and Hirota, {William K.} and Adler, {Douglas G.} and Davila, {Raquel E.} and Jacobson, {Brian C.} and Leighton, {Jonathan A} and Qureshi, {Waqar A.} and Elizabeth Rajan and Hambrick, {R. David} and Fanelli, {Robert D.} and Baron, {Todd H.} and Faigel, {Douglas Orrick}",
year = "2005",
month = "2",
doi = "10.1016/S0016-5107(04)02392-2",
language = "English (US)",
volume = "61",
pages = "189--194",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - ASGE guideline

T2 - The management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures

AU - Zuckerman, Marc J.

AU - Hirota, William K.

AU - Adler, Douglas G.

AU - Davila, Raquel E.

AU - Jacobson, Brian C.

AU - Leighton, Jonathan A

AU - Qureshi, Waqar A.

AU - Rajan, Elizabeth

AU - Hambrick, R. David

AU - Fanelli, Robert D.

AU - Baron, Todd H.

AU - Faigel, Douglas Orrick

PY - 2005/2

Y1 - 2005/2

N2 - This is one of a series of statements discussing the utilization of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy prepared this text. In preparing this guideline, a MEDLINE literature search was performed, and additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When little or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus. Further controlled clinical studies are needed to clarify aspects of this statement, and revision may be necessary as new data appear. Clinical consideration may justify a course of action at variance to these recommendations.

AB - This is one of a series of statements discussing the utilization of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy prepared this text. In preparing this guideline, a MEDLINE literature search was performed, and additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When little or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate use of endoscopy are based on a critical review of the available data and expert consensus. Further controlled clinical studies are needed to clarify aspects of this statement, and revision may be necessary as new data appear. Clinical consideration may justify a course of action at variance to these recommendations.

UR - http://www.scopus.com/inward/record.url?scp=13844305780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844305780&partnerID=8YFLogxK

U2 - 10.1016/S0016-5107(04)02392-2

DO - 10.1016/S0016-5107(04)02392-2

M3 - Article

C2 - 15729224

AN - SCOPUS:13844305780

VL - 61

SP - 189

EP - 194

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 2

ER -